|
Reports
for
NATAP from |
The 36th Annual Meeting of EASL |
April
18-22, 2001
Prague, Czech Republic |
Amantadine+Interferon/Ribivarin
in Interferon Non-Responders
Randomized,
Controlled Trial with Interferon-Alpha (IFN-ALPHA) Combined with
Ribavirin, With and Without Amantadine Sulfate in Primary IFN-Alpha
Nonresponsive Patients with Chronic Hepatitis C
(5/07/2001)
Durability
of Sustained Virologic Response: 3 year follow-up
Durability of Viral Response to Interferon Ribavirin Combination in Patients
with Chronic Hepatitis C: of
311 SVRs, during 3 years follow-up 7 patients had late relapse
(5/07/2001)
Entecavir:
new Hepatitis B drug in early research
A Phase II Study of
Entecavir vs. Lamivudine in Adulst with Chronic Hepatitis B
(5/07/01)
Maximine + Interferon Update
Reported by Jules Levin
(5/06/01)
IL-2
and Hepatitis: French research group reports IL-2 did not improve HCV or
HBV viral load & ALT
Reported
by Jules Levin
(5/04/01)
Highlights from the
36th Annual Meeting of EASL:
Part 1
(Preliminary
Results of Pegasys (pegylated interferon) plus Ribavirin Study for Chronic
Hepatitis C)
Part
2
(18
Months of Dual Therapy for Chronic Hepatitis C Decreases Relapse Rate and
Suggests New Treatment Approach for Hard to Treat Patients with Cirrhosis,
Genotype 1, and High Baseline Viral load)
Part 3
(New
ìMeta-analysisî Confirms Liver Fibrosis Regression after Treatment for Chronic
Hepatitis C)
Part 4
Peginterferon
Alfa-2b (PegIntron) Plus Ribavirin Update (Section A)
Part 5
Peginterferon
Alfa-2b (PegIntron) Plus Ribavirin Update (Section B)
Part 6
HIV/HBV
Co-Infection Reports at 36th EASL (Section A)
Part 7
HIV/HBV
Co-Infection Reports at 36th EASL (Section B)
Part 8
Interim
Peginterferon alfa 2a (Pegasys) Updates from 36th EASL
Part 9
Does Treating HIV Decrease
HCV Transmission to Newborns of HIV/HCV Co-Infected Mothers?
All parts written for NATAP by Harvey S. Bartnof, MD Staff Physician at
AVERI, AIDS Virus Education and Research Institute in San Francisco, CA.
ALT Levels (liver enzymes)
Can Be Normal But Liver Disease Can Be Advanced
Written by Jules Levin
Predictive
Value of ALT Levels On Histological Findings in Chronic Hepatitis C: A European
Collaborative Study
&...
HCV Carriers with
Normal ALT: Healthy People or Patients with Chronic Hepatitis? The Italian
Study of the Asymptomatic C Carriers (ISACC)
(5/01/01)